About the Company
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
2112
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on GLOBUS MEDICAL INC
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
Globus Medical, Inc. GMED reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, which surpassed the ...
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Welcome to Globus Medical’s Second Quarter 2025 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior ...
Globus Wins $9.5 Million From Life Spine at Patent Jury Trial
Life Spine Inc. owes Globus Medical Inc. $9.5 million after a federal jury in Delaware found four models in its ProLift line ...
Globus Medical, Inc. Scheduled to Release Q1 2025 Financial ... - Nasdaq
Quiver AI Summary Globus Medical, Inc. announced that it will release its financial results for the first quarter ended March 31, 2025, after market close on May 8, 2025.
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript
Globus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Conference Call February 20, 2024 4:30 PM ETCompany ParticipantsBrian Kearns - Senior Vice President, ...
Globus Medical Inc - Class A - 24/7 Wall St.
Globus Medical Inc is a leading innovator in the medical device industry, focusing on developing solutions for musculoskeletal disorders. With a broad portfolio, the company offers spine products ...
Globus Medical Announces Leadership Transitions and Preliminary Second ...
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief ...
Globus Medical Reports Second Quarter 2025 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the ...
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run ... - Nasdaq
For the current fiscal year, Globus Medical is expected to post earnings of $2.95 per share on $2.5 billion in revenues. This represents a 27.16% change in EPS on a 59.19% change in revenues.
Globus Medical, Inc. (GMED) Q1 2023 Earnings Call Transcript
Globus Medical, Inc. (NYSE: GMED) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations ...
Similar Companies
Loading the latest forecasts...